KARBE FRANK 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-23−17,500→ 17,500 totalExercise: $10.30Exp: 2034-05-22→ Common Stock (17,500 underlying) - Award
Common Stock
2024-05-23+10,500→ 19,500 total
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") were granted on May 23, 2024, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.